Investigational drug · Phase 2
GRT7040
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Pain, Bunionectomy.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "GRT7040"
First trial start
2026
Sep 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "GRT7040", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Pain
- Bunionectomy
Approved drugs for the same conditions: Acute pain · Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "GRT7040" as an intervention, largest first.
- A Clinical Trial of GRT7040 in Adults With Acute Pain Following BunionectomyPivotal-lookingNot yet recruiting
Grünenthal GmbHIndustry
NCT07807644 · 400 participants (planned) · Start Sep 2026 · Primary completion Sep 2027
Drug: GRT7040; Hydrocodone bitartrate/ acetaminophen (HB/APAP) and 2 more · For: Acute Pain; Bunionectomy
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Acute Pain
- CebranopadolTRN-228Phase 34 trials
Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain
- MR-107A-02Phase 31 trial
Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- LY4515100Phase 21 trial
Eli Lilly · Acute Pain, Molar, Molar, Third
- SRP-001Phase 21 trial
South Rampart Pharma, Inc. · Acute Pain, Postoperative Pain, Pain
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.